Observational analysis identifies prostate cancer progression risk using MRI embeddings, indicating potential for improved patient selection.
Motivation: Patients with low-risk prostate cancer are often put under active surveillance (AS) to delay treatment until cancer progression. Selecting correctly is crucial to disease management. Goal(s): The aim is to determine if the embeddings of U-Found can be utilized to assist in the clinical decision making whether a patient is at high risk for progression. Approach: Using multiparametric (mp)MRI data from contemporary clinical trial, we obtained embeddings from Apparent Diffusion Coefficient (ADC) maps. We developed a model using features related to progression. Results: The prediction model reached AUC of 97%, indicating strong cancer signal available in the embeddings. Impact: We present an application of novel MRI-based foundation model of the prostate to assess prostate cancer progression risk for AS patients, thereby providing essential data for clinicians that can prospectively improve AS patient selection.
No takes yet. Share an insight, caveat, or question.
Breto et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: